Browse the evidence

The most beneficial type of diet for weight loss remains up for debate.

Practitioners should be aware of the ongoing discussions about diet effectiveness.

The visual-textual integrator of iFood achieved an accuracy of 51.38% in identifying diet images and information.

The accuracy of the app's data integration can be improved for better dietary insights.

Current genomic risk scores alone may not lead to superior weight loss.

Practitioners should not rely solely on genomic risk scores for weight loss strategies.

There is a need for multiomicron integration in personalized nutrition.

Practitioners should consider integrating various omics data for more effective personalized nutrition strategies.

Much remains to be done to make PN interventions more effective and equitable.

Efforts should focus on improving the design and implementation of PN interventions to enhance their effectiveness and accessibility.

The MM diet did not reduce fat mass compared to a usual diet (UD) with a mean difference of -11.36 kg.

Practitioners should be cautious in recommending MM diets for fat loss compared to usual diets.

Less than half of primary care visits include some type of physical activity promotion.

Healthcare providers should prioritize physical activity promotion during patient visits.

Cognitive scores were lower with increasing BF percentage and VAT.

Monitoring body fat percentage and visceral fat may be important for cognitive health.

Predisposing risk factors for antipsychotic-induced weight gain (AIWG) include lack of prior AP exposure, sex, and age.

Clinicians should consider these risk factors when prescribing antipsychotics.

The gut microbiome may contribute to the development of obesity in humans.

Practitioners should consider the gut microbiome as a potential factor in obesity management.

A comprehensive redefinition of obesity in Asian Indians is needed beyond BMI criteria.

Practitioners should consider factors beyond BMI when diagnosing obesity in Asian Indians.

Stage 2 obesity requires excess waist circumference or waist-to-height ratio, along with symptoms or comorbid conditions.

Practitioners should assess waist measurements and related symptoms for obesity classification.

The refined framework aims to enhance precision in identifying obesity and its health risks.

Practitioners can use this framework to better assess obesity-related health risks.

The decision tree yields an AUC of 0.898 for phenotyping PCOS.

Clinicians can utilize this decision tree for effective phenotyping of PCOS.

The decision tree aims to improve PCOS management by reducing multiple blood tests and physician workload.

This decision tree could streamline the diagnostic process for PCOS, making it more efficient for healthcare providers.

Different studies report conflicting results regarding the beneficial role of Blautia in obesity.

Practitioners should be aware of the mixed evidence regarding Blautia's role in obesity when considering interventions.

The US Office of Personnel Management requires adequate coverage of FDA-approved antiobesity medications.

Health practitioners should understand the implications of this coverage requirement for their patients.

Expanded insurance coverage for bariatric surgery provides lessons for antiobesity medication coverage.

Understanding these parallels can help advocate for better coverage of antiobesity medications.

206,361 individuals (68.6%) had obesity according to the new definition compared to 128,992 individuals (42.9%) according to the traditional definition.

Practitioners should consider the new definition of obesity when assessing patients.

108,650 individuals (36.1%) had clinical obesity according to the new definition, with prevalence increasing with age.

Age should be considered when evaluating obesity risk in patients.

Collaboration between oncologists and obesity treatment experts is increasingly important.

Healthcare systems should foster interdisciplinary collaboration.

Short term dietary trials are highly susceptible to bias due to physiological adaptation to major changes in nutrients.

Practitioners should be aware that results from short-term dietary trials may be influenced by the time it takes for physiological changes to occur.

The article proposes measures to strengthen causal inference in dietary trials.

Implementing proposed measures could enhance the reliability of findings in dietary research.

The overall incidence of remissions per 1000 person-years was 10.5.

Practitioners should be aware of the remission rates in this population.